Skip to content

Clinical trials

Phase 1/2 Lymphoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Country / region: Belgium Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20162
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting2
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines1
Incyte Biosciences International Sàrl1
Incyte Corporation1
OSE Immunotherapeutics1
Pfizer1
Taiho Oncology, Inc.1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma7
Carcinoma, Non-Small-Cell Lung2
Leukemia2
Blast Crisis1
Breast Neoplasms1
Colorectal Neoplasms1
Glioblastoma1
Leukemia, Myeloid, Accelerated Phase1
Leukemia, Myeloid, Acute1
Leukemia, Myeloid, Chronic-Phase1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.